Canada markets closed

ChemoCentryx, Inc. (CCXI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
19.20+0.03 (+0.16%)
At close: 04:00PM EDT
19.00 -0.20 (-1.04%)
After hours: 05:43PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.36B
Enterprise Value 1.10B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)49.56
Price/Book (mrq)5.28
Enterprise Value/Revenue 40.42
Enterprise Value/EBITDA -8.18

Trading Information

Stock Price History

Beta (5Y Monthly) 1.84
52-Week Change 393.83%
S&P500 52-Week Change 3-3.35%
52 Week High 342.16
52 Week Low 39.53
50-Day Moving Average 321.84
200-Day Moving Average 326.44

Share Statistics

Avg Vol (3 month) 31.45M
Avg Vol (10 day) 32.69M
Shares Outstanding 571.19M
Implied Shares Outstanding 6N/A
Float 858.47M
% Held by Insiders 111.96%
% Held by Institutions 176.20%
Shares Short (Apr 28, 2022) 46M
Short Ratio (Apr 28, 2022) 45.13
Short % of Float (Apr 28, 2022) 410.45%
Short % of Shares Outstanding (Apr 28, 2022) 48.43%
Shares Short (prior month Mar 30, 2022) 47.22M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Dec 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)-403.17%

Management Effectiveness

Return on Assets (ttm)-17.19%
Return on Equity (ttm)-39.23%

Income Statement

Revenue (ttm)32.22M
Revenue Per Share (ttm)0.46
Quarterly Revenue Growth (yoy)-46.90%
Gross Profit (ttm)-51.07M
EBITDA -126.78M
Net Income Avi to Common (ttm)-131.75M
Diluted EPS (ttm)-1.89
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)264.49M
Total Cash Per Share (mrq)3.73
Total Debt (mrq)73.28M
Total Debt/Equity (mrq)25.61
Current Ratio (mrq)4.27
Book Value Per Share (mrq)4.07

Cash Flow Statement

Operating Cash Flow (ttm)-75.62M
Levered Free Cash Flow (ttm)-70.88M